We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
-$14.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
1.3 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
3.8 quarters
Top 10 Avg Time Held Equity only
1.3 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Buys

Rank Stock Value
1
DFS icon
Discover Financial Services
DFS
+$191M
2
SMAR icon
Smartsheet Inc.
SMAR
+$188M
3
FYBR icon
Frontier Communications
FYBR
+$124M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR icon
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT icon
CATALENT, INC.
CTLT
+$234M
2
MRO icon
Marathon Oil Corporation
MRO
+$222M
3
SRCL icon
Stericycle Inc
SRCL
+$172M
4
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT icon
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
COTY icon
176
PUT
Coty
COTY
$2.51B
$1.62M 0.04%
1,264,500
– –
2023 Q3
5 quarters
ALGS icon
177
Aligos Therapeutics
ALGS
$33.3M
$1.6M 0.04%
40,096
-27,000
-40% -$522K
2024 Q1
3 quarters
ADT icon
178
ADT
ADT
$4.7B
$1.59M 0.04%
229,607
– –
2018 Q2
26 quarters
IFRX icon
179
InflaRx
IFRX
$236M
$1.55M 0.04%
625,589
-172,287
-22% -$331K
2023 Q2
6 quarters
BAP icon
180
Credicorp
BAP
$30.3B
$1.52M 0.04%
8,311
– –
2024 Q3
1 quarter
KIDS icon
181
OrthoPediatrics
KIDS
$565M
$1.51M 0.04%
65,292
+13,270
+26% +$332K
2022 Q1
11 quarters
ALGN icon
182
Align Technology
ALGN
$10.1B
$1.51M 0.04%
7,250
+1,800
+33% +$402K
2024 Q2
2 quarters
FFIV icon
183
F5
FFIV
$27.2B
$1.51M 0.04%
+6,000
New +$1.43M
2024 Q4
0 quarters
SWTX icon
184
DELISTED
SpringWorks Therapeutics
SWTX
$1.5M 0.04%
41,493
+12,980
+46% +$454K
2022 Q1
11 quarters
POLE icon
185
Andretti Acquisition Corp II
POLE
$147M
$1.5M 0.04%
+150,000
New +$1.5M
2024 Q4
0 quarters
NKTR icon
186
Nektar Therapeutics
NKTR
$1.41B
$1.47M 0.04%
105,394
+28,672
+37% +$506K
2023 Q3
5 quarters
INCY icon
187
Incyte
INCY
$22.9B
$1.46M 0.04%
21,188
-2,683
-11% -$191K
2023 Q1
7 quarters
KALV icon
188
DELISTED
KalVista Pharmaceuticals
KALV
$1.46M 0.04%
172,693
+37,141
+27% +$385K
2024 Q1
3 quarters
ZS icon
189
Zscaler
ZS
$38.1B
$1.46M 0.04%
8,100
+4,100
+103% +$794K
2024 Q3
1 quarter
CAPR icon
190
Capricor Therapeutics
CAPR
$455M
$1.45M 0.04%
104,798
+21,898
+26% +$384K
2024 Q3
1 quarter
FNA icon
191
DELISTED
Paragon 28, Inc.
FNA
$1.43M 0.04%
138,854
-11,964
-8% -$96.6K
2023 Q1
7 quarters
AGIO icon
192
Agios Pharmaceuticals
AGIO
$1.9B
$1.42M 0.04%
43,330
+22,243
+105% +$1.04M
2022 Q4
8 quarters
RIGL icon
193
Rigel Pharmaceuticals
RIGL
$917M
$1.42M 0.04%
84,311
-32,604
-28% -$625K
2022 Q1
11 quarters
CRNX icon
194
DELISTED
Crinetics Pharmaceuticals
CRNX
$1.42M 0.04%
27,687
+2,994
+12% +$168K
2022 Q1
11 quarters
ORIC icon
195
Oric Pharmaceuticals
ORIC
$1.24B
$1.41M 0.04%
174,846
+31,526
+22% +$289K
2022 Q2
10 quarters
YUMC icon
196
Yum China
YUMC
$14.5B
$1.39M 0.03%
+28,900
New +$1.37M
2024 Q4
0 quarters
STNE icon
197
StoneCo
STNE
$2.87B
$1.38M 0.03%
173,478
+9,620
+6% +$97.5K
2024 Q2
2 quarters
PLRX icon
198
Pliant Therapeutics
PLRX
$63.2M
$1.36M 0.03%
103,563
+18,678
+22% +$255K
2024 Q2
2 quarters
RLAY icon
199
Relay Therapeutics
RLAY
$3.92B
$1.36M 0.03%
330,699
+218,651
+195% +$1.19M
2024 Q3
1 quarter
IMCR icon
200
Immunocore
IMCR
$1.51B
$1.34M 0.03%
45,274
+10,162
+29% +$321K
2022 Q1
11 quarters
6 7
8
9 10

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.